SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001651308-21-000046
Filing Date
2021-03-05
Accepted
2021-03-05 16:07:52
Documents
15
Period of Report
2021-03-05
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K bgne-20210305.htm   iXBRL 8-K 42092
2 EX-99.1 a8-kex991x3x5x2021.htm EX-99.1 29376
  Complete submission text file 0001651308-21-000046.txt   227712

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT bgne-20210305.xsd EX-101.SCH 2505
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT bgne-20210305_cal.xml EX-101.CAL 793
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT bgne-20210305_def.xml EX-101.DEF 1757
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT bgne-20210305_lab.xml EX-101.LAB 25214
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT bgne-20210305_pre.xml EX-101.PRE 13249
8 EXTRACTED XBRL INSTANCE DOCUMENT bgne-20210305_htm.xml XML 11810
Mailing Address C/O MOURANT GOVERNANCE SERVICES (CAYMAN) 94 SOLARIS AVENUE, CAMANA BAY GRAND CAYMAN E9 KY1-1108
Business Address C/O MOURANT GOVERNANCE SERVICES (CAYMAN) 94 SOLARIS AVENUE, CAMANA BAY GRAND CAYMAN E9 KY1-1108 13459494123
BeiGene, Ltd. (Filer) CIK: 0001651308 (see all company filings)

IRS No.: 981209416 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37686 | Film No.: 21718559
SIC: 2834 Pharmaceutical Preparations